Navigation Links
Drug-Eluting Stents Outperform Bare Stents in Heart Attack
Date:3/30/2008

ively, at 30 days and 12.3 percent vs. 9.9 percent, respectively, at eight months. The rates of minor and major bleeding did not differ in the two groups, but a marked drop in the blood platelet count -- a complication that could cause uncontrolled bleeding -- was more common among patients treated with abciximab (4.0 percent vs. 0.8 percent, p=0.004).

When comparing the two types of stents, investigators found an equivalent MACE rate at 30 days (3.9 percent vs. 5.9 percent, p=0.12) with sirolimus-eluting and bare-metal stents. However, at eight months, the MACE rate was significantly lower with drug-eluting stents (7.8 percent vs. 14.5 percent, p=0.0039). This difference was mainly driven by a 69 percent reduction in the need for a repeat procedure to reopen the treated coronary artery (3.2 percent with sirolimus-eluting stents vs. 10.2 percent with bare-metal stents, p=0.0004). The rates of death and repeat heart attack were similar, as was the incidence of stent thrombosis.

"Our study shows that tirofiban is 'noninferior' in its efficacy to abciximab in this high-risk patient population, and has a better safety profile," said Dr. Valgimigli. "We have also confirmed that, even in STEMI patients, drug-eluting stents are highly effective in reducing reintervention in the target vessel. More important, this came without an extra price to pay in terms of death, myocardial infarction or stent thrombosis."

Dr. Valgimigli will present the results of this study on Sunday, March 30 at 9:00 a.m. CDT in the Grand Ballroom, S100. This study will simultaneously publish in JAMA: Journal of the American Medical Association.

About SCAI

Headquartered in Washington, DC, the Society for Cardiovascular Angiography and Interventions is a 4,000-member professional organization representing invasive and interventional cardiologists in over 60 nations. SCAI's mission is to promote excellence in invasive and interventional cardiovascular medicine through
'/>"/>

SOURCE SCAI-ACCi2
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
2. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
3. OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
4. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study
7. BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
8. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
9. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
10. American Heart Association Journal Report: Reducing Kids Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014  Kindred Hospital Houston Northwest, with ... opening of its new outpatient wound healing center.  ... people with chronic, hard to heal wounds. Chronic ... to amputation, lower leg wounds related to blood ... and traumatic injury wounds which are complex and ...
(Date:7/11/2014)... July 11, 2014 On ... down 0.52%, the Dow Jones Industrial Average finished the day ... 1,964.68, down 0.41%. The losses were broad based as eight ... S&P 500 Health Care Sector Index ended the day at ... the last one month. Investor-Edge has initiated coverage on the ...
(Date:7/11/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ... "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: ... 6% and is expected to be valued at ... http://photos.prnewswire.com/prnh/20130307/600769 ... been segmented according to immunoprotein types which include ...
Breaking Medicine Technology:Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2
... DIEGO , May 5 Volcano Corporation (Nasdaq: VOLC ... designed to enhance the diagnosis and treatment of coronary and peripheral vascular ... America Merrill Lynch Health Care Conference on Tuesday, May 11 . ... The presentation by ...
... , ABBOTT PARK, Ill., May 5 Abbott (NYSE: ... on Friday, June 4, 2010 in New York City . ... on the company at 9 a.m. Central time . , ... A live audio webcast of the presentation will be ...
Cached Medicine Technology:Volcano Corporation Presentation at Bank of America Merrill Lynch Health Care Conference to Be Webcast 2
(Date:7/14/2014)... New research and analysis from the national ... examines toxic ingredients in tampons, a product used ... chemicals that may be found in the product’s absorptive ... put women’s health at risk. , According to ... , the potential impact of toxic chemical exposure from ...
(Date:7/13/2014)... (PRWEB) July 14, 2014 FORT LEE, N.J. ... tackle the modern approach to the science of tooth ... Implant. This book describes recent advances and techniques ... methodological approaches that benefit people who have lost all of ... inserted the first lower subperiosteal implant in 1940. ...
(Date:7/13/2014)... MA (PRWEB) July 14, 2014 MED-Ed ... presenting at our next conference, April 7+8 in Boston ... well attended at the recent event. Presentations by individuals ... 2014. , To review the types of sessions that ... , Submit your proposal today! , Conference ...
(Date:7/13/2014)... 14, 2014 Worldwide ladies are extremely ... Angeldress.co.uk has taken a different approach and has created ... are offered in more colour choices that responded directly ... brand of women’s special occasion apparels. The company’s pink ... specialists are working hard to create the best products ...
(Date:7/13/2014)... July 13, 2014 Ticket Down ... Madrid Tickets . For the fifth straight year (and ... will be held at American stadiums this summer. The tournament ... American soil. The eight teams are split into two groups ... the top two teams will compete to become champion. One ...
Breaking Medicine News(10 mins):Health News:New Patent Analysis Shows Toxic Risk From Tampons 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 3Health News:New Patent Analysis Shows Toxic Risk From Tampons 4Health News:New Patent Analysis Shows Toxic Risk From Tampons 5Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 2Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 3Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 4Health News:MED-Ed Facilities Conference Call for Speakers Open 2Health News:Angeldress.co.uk Announces Summer Sale For Pink And Red Bridesmaid Dresses; The Current Discount Is Up To 80% Off 2Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 2Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 3
... Genomatix Software Inc., the newly incorporated subsidiary of Genomatix Software ... software licensing agreement with the NCI/NIH for the fourth consecutive ... history as the renewal was executed entirely between the US ... We are extremely pleased with our progress in putting the ...
... Rice University Psychology Professor Tony Ro has published its ... as synesthesia, in which stimulation of one sensory pathway ... pathway. , Ro,s paper, Feeling Sounds After a Thalamic ... the official journal of the American Neurological Association. The ...
... - Researchers at the Centre for Addiction and Mental ... and the risk of head and neck cancers, showing ... cancer risk. , According to CAMH Principal Investigator ... between alcohol consumption and an increased risk for cancer ...
... Drug Discovery Projects, REDWOOD CITY, Calif., Sept. ... announced today that it has obtained,commitments from several ... its common stock and warrants to purchase,approximately 2.6 ... proceeds of,approximately $23.7 million. The investors have agreed ...
... form of care, experts say , WEDNESDAY, Sept. ... issued new "performance measures" meant to boost patient enrollment ... heart attack patients aren,t getting the benefit of this ... set standards of excellence for these programs and are ...
... The close of summer traditionally,marks the return to ... fall,and holiday baking seasons. This year, in response to ... cooking is a growing,trend. A study published in the ... in kids, body mass index occur during the summer,months, ...
Cached Medicine News:Health News:Research at Rice may help explain aspects of synesthesia 2Health News:Research at Rice may help explain aspects of synesthesia 3Health News:Alcohol and cancer: is drinking the new smoking? 2Health News:Genelabs Technologies Announces Commitments to Raise $23.7 Million in a Registered Direct Financing 2Health News:Heart Attack Survivors Benefit From Rehab 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 3Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 4
... complete line of enteric disease ... and monoclonal/polyclonal antibody-based ELISA tests ... pathogens in fecal specimens. Our ... difficile, Entamoeba histolytica, Giardia, Cryptosporidium ...
... II test is also available with Inverness ... greatly reduces the hands-on time required to ... testing. The Fecal-Quik-Prep device is a unique ... amount of hands-on time required to prepare ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
Medicine Products: